| Product NDC: | 0517-0830 |
| Proprietary Name: | Latanoprost |
| Non Proprietary Name: | Latanoprost |
| Active Ingredient(s): | 50 ug/mL & nbsp; Latanoprost |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0517-0830 |
| Labeler Name: | American Regent, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA200925 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110802 |
| Package NDC: | 0517-0830-01 |
| Package Description: | 1 BOTTLE, PLASTIC in 1 CARTON (0517-0830-01) > 2.5 mL in 1 BOTTLE, PLASTIC |
| NDC Code | 0517-0830-01 |
| Proprietary Name | Latanoprost |
| Package Description | 1 BOTTLE, PLASTIC in 1 CARTON (0517-0830-01) > 2.5 mL in 1 BOTTLE, PLASTIC |
| Product NDC | 0517-0830 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Latanoprost |
| Dosage Form Name | SOLUTION |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 20110802 |
| Marketing Category Name | ANDA |
| Labeler Name | American Regent, Inc. |
| Substance Name | LATANOPROST |
| Strength Number | 50 |
| Strength Unit | ug/mL |
| Pharmaceutical Classes | Prostaglandin Analog [EPC],Prostaglandins [Chemical/Ingredient] |